Live Breaking News & Updates on Globe Newswire Inmune Bio Inc

Stay updated with breaking news from Globe newswire inmune bio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

INmune Bio, Inc. Announces Second Quarter 2021 Results and

INmune Bio, Inc. Announces Second Quarter 2021 Results and
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , David Moss , Inmune Biocontact , Recentcorporatehighlights Inkmune Platformhighlights , Inmune Bio , Mark Lowdell , Chuck Padala , Silicon Valley Bank , Globe Newswire Inmune Bio Inc , Alzheimer Association International Conference , Company Current Reports On Form , Company Quarterly Reports On Form , Company Annual Report On Form , Exchange Commission , Aboutinmunebio Inc , Association International Conference , Fiber Density , Treatment Resistant Depression , Professor Mark Lowdell , Natural Killer , Data Safety Monitoring Board , Resultsforthesecondquarterended June , Natural Killer Cell Priming Platform , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports ,

INmune Bio : Announces Poster Presentation and Plenary Talk at the Alzheimer's Association International Conference 2021 (Form 8-K)

INmune Bio : Announces Poster Presentation and Plenary Talk at the Alzheimer's Association International Conference 2021 (Form 8-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , David Moss , Malu Tansey , Inmune Bio , Boca Raton , Malug Tansey , Michael Tattory , Chuck Padala , Globe Newswire Inmune Bio Inc , Translational Research In Neurodegenerative Disease , Parkinson Foundation Research Center , Department Of Neurology , Alzheimer Association International Conference , Inmune Bio Inc , Company Current Reports On Form , Alzheimer Association International Congress , Company Quarterly Reports On Form , Exchange Commission , Company Annual Report On Form , Lifesci Communications , University Of Florida College Medicine , Announces Poster Presentation , Plenary Talk , Association International Conference , Association International Congress , Florida College ,

INmune Bio, Inc. to Participate in Alzheimer Disease Panel

Panel Session Title: Alzheimer Disease Panel
Date and Time: Wednesday May 26th, 11:00 a.m. Eastern time (8:00 a.m. Pacific time)
Presented by: Maxim Group LLC | Hosted by: M-Vest
Moderated by: Dr. Jason McCarthy
About INmune Bio, Inc.
INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and mechanistic target of many diseases. DN-TNF is currently being developed for COVID-19 complications (Quellor™), cancer (INB03™), Alzheimer’s and Treatment Resistant Depression (XPro1595), and NASH (LIVNate™). The Natural Killer Cell Priming Platform includes INKmune™ aimed at priming the patient’s NK cells to eliminate minimal residual disease in patient ....

David Moss , Jason Mccarthy , Inmune Bio , Annovis Bio , Chuck Padala , Globe Newswire Inmune Bio Inc , Biotechnology Equity Research , Inmune Bio Inc , Company Current Reports On Form , Head Of Biotechnology Research At Maxim Group , Company Quarterly Reports On Form , Exchange Commission , Panel Session Title , Company Annual Report On Form , Maxim Group , Alzheimer Disease Panel , Cassava Sciences , Wednesday May , Senior Managing Director , Prescription Drug User Free Act , Vivoryon Therapeutics , Cyclo Therapeutics , Biotechnology Research , Session Title , Alzheimer Disease , Treatment Resistant Depression ,